{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:49:40Z","timestamp":1779299380226,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.euroneuro.2007.03.005","type":"journal-article","created":{"date-parts":[[2007,5,4]],"date-time":"2007-05-04T11:24:19Z","timestamp":1178277859000},"page":"637-642","source":"Crossref","is-referenced-by-count":20,"title":["Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine (m-CPP) in patients with generalized social anxiety disorder, panic disorder and healthy controls"],"prefix":"10.1016","volume":"17","author":[{"given":"J.F.","family":"Van Veen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.J.A.","family":"Van der Wee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Fiselier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.M.","family":"Van Vliet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.G.M.","family":"Westenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2007.03.005_bib1","first-page":"21","article-title":"Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project","volume":"420","author":"Alonso","year":"2004","journal-title":"Acta Psychiatr. Scand., Suppl."},{"key":"10.1016\/j.euroneuro.2007.03.005_bib2","first-page":"28","article-title":"12-Month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project","volume":"420","author":"Alonso","year":"2004","journal-title":"Acta Psychiatr. Scand., Suppl."},{"key":"10.1016\/j.euroneuro.2007.03.005_bib3","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0005-7967(00)00095-4","article-title":"The catastrophic misinterpretation model of panic disorder","volume":"39","author":"Austin","year":"2001","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.euroneuro.2007.03.005_bib4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1017\/S1461145703003791","article-title":"The evidence-based pharmacological treatment of social anxiety disorder","volume":"6","author":"Blanco","year":"2003","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2007.03.005_bib5","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0006-3223(92)90179-4","article-title":"A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder","volume":"32","author":"Bradwejn","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.005_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0165-1781(97)00038-3","article-title":"The 35% CO2 challenge test in patients with social phobia","volume":"71","author":"Caldirola","year":"1997","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2007.03.005_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1034\/j.1600-0447.108.s417.3.x","article-title":"Neuroanatomical circuits modulating fear and anxiety behaviors","author":"Charney","year":"2003","journal-title":"Acta Psychiatr. Scand., Suppl."},{"key":"10.1016\/j.euroneuro.2007.03.005_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF00215473","article-title":"Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects","volume":"92","author":"Charney","year":"1987","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2007.03.005_bib9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.janxdis.2004.12.003","article-title":"No distinctions between different types of anxiety symptoms in pre-adolescents from the general population","volume":"20","author":"Ferdinand","year":"2006","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.euroneuro.2007.03.005_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0165-1781(94)90001-9","article-title":"Response to meta-chlorophenylpiperazine in panic disorder patients and healthy subjects: influence of reduction in intravenous dosage","volume":"54","author":"Germine","year":"1994","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2007.03.005_bib11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/0006-3223(90)90510-9","article-title":"High-dose carbon dioxide challenge test in anxiety disorder patients","volume":"28","author":"Gorman","year":"1990","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.005_bib12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archpsyc.62.2.182","article-title":"The structure of genetic and environmental risk factors for anxiety disorders in men and women","volume":"62","author":"Hettema","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.005_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0165-1781(98)00041-9","article-title":"Serotonergic function in social phobia: comparison to normal control and obsessive\u2013compulsive disorder subjects","volume":"79","author":"Hollander","year":"1998","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2007.03.005_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0005-7967(89)90044-2","article-title":"Provocation of panic: three elements of the panic reaction in four anxiety disorders","volume":"27","author":"Holt","year":"1989","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.euroneuro.2007.03.005_bib15","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF00216062","article-title":"Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder","volume":"96","author":"Kahn","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2007.03.005_bib16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0924-977X(01)00100-6","article-title":"Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors","volume":"11","author":"Kasper","year":"2001","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2007.03.005_bib17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s11920-003-0055-8","article-title":"Neurocircuitry of anxiety disorders","volume":"5","author":"Kent","year":"2003","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.euroneuro.2007.03.005_bib18","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0006-3223(91)90119-7","article-title":"Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects","volume":"30","author":"Klein","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.005_bib19","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1176\/ajp.142.8.947","article-title":"Specificity of lactate infusions in social phobia versus panic disorders","volume":"142","author":"Liebowitz","year":"1985","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.005_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archpsyc.1996.01830020077009","article-title":"Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey","volume":"53","author":"Magee","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.005_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0893-133X(96)00197-2","article-title":"A comparison of the effects of intravenous pentagastrin on patients with social phobia, panic disorder and healthy controls","volume":"16","author":"McCann","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2007.03.005_bib22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1176\/ajp.150.2.250","article-title":"Diagnostic and substance specificity of carbon-dioxide-induced panic","volume":"150","author":"Papp","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.005_bib23","unstructured":"Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., Herqueta, T., Baker, R., Dunbar, G.C. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J.Clin.Psychiatry 59 Suppl;20,22\u201333; quiz 34\u201357, 22\u201333."},{"key":"10.1016\/j.euroneuro.2007.03.005_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1176\/appi.ajp.159.1.55","article-title":"Gender differences in panic disorder: findings from the National Comorbidity Survey","volume":"159","author":"Sheikh","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.005_bib25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0378-4347(00)82380-4","article-title":"High-performance liquid chromatographic method for the analysis of plasma m-chlorophenylpiperazine","volume":"528","author":"Suckow","year":"1990","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.euroneuro.2007.03.005_bib26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0006-3223(93)90150-C","article-title":"Growth hormone response to intravenous clonidine in social phobia: comparison to patients with panic disorder and healthy volunteers","volume":"34","author":"Tancer","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.005_bib27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/anxi.3070010307","article-title":"Lactic acid response to caffeine in panic disorder: comparison with social phobics and normal controls","volume":"1","author":"Tancer","year":"1994","journal-title":"Anxiety"},{"key":"10.1016\/j.euroneuro.2007.03.005_bib28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.euroneuro.2004.01.001","article-title":"Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine in patients with panic disorder and controls","volume":"14","author":"Van der Wee","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2007.03.005_bib30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF02249335","article-title":"Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients","volume":"114","author":"Van Megen","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2007.03.005_bib29","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/0006-3223(96)00250-8","article-title":"Effect of the cholecystokinin-B receptor antagonist L-365,260 on lactate-induced panic attacks in panic disorder patients","volume":"40","author":"Van Megen","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.005_bib31","unstructured":"Van Vliet, I.M., De Beurs, E., in press. De MINI-internationaal Psychiatrisch Interview: een kort gestructureerd en diagnostisch psychiatrisch interview voor DSM-IV en ICD-10 psychiatrische stoornissen. Tijdschrift voor Psychiatrie (www.tvp.nl)."},{"key":"10.1016\/j.euroneuro.2007.03.005_bib32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0006-3223(97)00185-6","article-title":"Anxiogenic effects of pentagastrin in patients with social phobia and healthy controls","volume":"42","author":"Van Vliet","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.005_bib33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/gb-2003-4-8-224","article-title":"Untangling genetic networks of panic, phobia, fear and anxiety","volume":"4","author":"Villafuerte","year":"2003","journal-title":"Genome Biol."},{"key":"10.1016\/j.euroneuro.2007.03.005_bib34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0165-1781(96)02001-X","article-title":"Serotonin function in panic disorder: intravenous administration of meta-chlorophenylpiperazine","volume":"64","author":"Wetzler","year":"1996","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2007.03.005_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0447.2000.tb10947.x","article-title":"Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors","volume":"403","author":"Zohar","year":"2000","journal-title":"Acta Psychiatr. Scand., Suppl."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X0700082X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X0700082X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T16:25:33Z","timestamp":1546878333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X0700082X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0924977X0700082X"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2007.03.005","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}